Cardio Diagnostics (CDIO) Competitors $3.88 -0.26 (-6.28%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$4.00 +0.13 (+3.22%) As of 08/1/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDIO vs. DYAI, SCYX, ENLV, NRSN, GBIO, NNVC, ALXO, QTTB, FBLG, and RANIShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Dyadic International (DYAI), SCYNEXIS (SCYX), Enlivex Therapeutics (ENLV), NeuroSense Therapeutics (NRSN), Generation Bio (GBIO), NanoViricides (NNVC), ALX Oncology (ALXO), Q32 Bio (QTTB), FibroBiologics (FBLG), and Rani Therapeutics (RANI). These companies are all part of the "pharmaceutical products" industry. Cardio Diagnostics vs. Its Competitors Dyadic International SCYNEXIS Enlivex Therapeutics NeuroSense Therapeutics Generation Bio NanoViricides ALX Oncology Q32 Bio FibroBiologics Rani Therapeutics Cardio Diagnostics (NASDAQ:CDIO) and Dyadic International (NASDAQ:DYAI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment. Does the media prefer CDIO or DYAI? In the previous week, Dyadic International had 3 more articles in the media than Cardio Diagnostics. MarketBeat recorded 3 mentions for Dyadic International and 0 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 0.00 equaled Dyadic International'saverage media sentiment score. Company Overall Sentiment Cardio Diagnostics Neutral Dyadic International Neutral Is CDIO or DYAI more profitable? Dyadic International has a net margin of -163.94% compared to Cardio Diagnostics' net margin of -28,539.39%. Cardio Diagnostics' return on equity of -84.55% beat Dyadic International's return on equity.Company Net Margins Return on Equity Return on Assets Cardio Diagnostics-28,539.39% -84.55% -74.63% Dyadic International -163.94%-233.69%-59.37% Do analysts prefer CDIO or DYAI? Cardio Diagnostics currently has a consensus price target of $60.00, indicating a potential upside of 1,446.39%. Dyadic International has a consensus price target of $6.00, indicating a potential upside of 497.01%. Given Cardio Diagnostics' higher probable upside, research analysts plainly believe Cardio Diagnostics is more favorable than Dyadic International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Dyadic International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, CDIO or DYAI? Dyadic International has higher revenue and earnings than Cardio Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardio Diagnostics$19.90K339.03-$8.38MN/AN/ADyadic International$3.34M9.04-$5.81M-$0.20-5.03 Which has more volatility & risk, CDIO or DYAI? Cardio Diagnostics has a beta of 2.96, indicating that its stock price is 196% more volatile than the S&P 500. Comparatively, Dyadic International has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Do institutionals & insiders believe in CDIO or DYAI? 8.1% of Cardio Diagnostics shares are owned by institutional investors. Comparatively, 28.0% of Dyadic International shares are owned by institutional investors. 22.3% of Cardio Diagnostics shares are owned by insiders. Comparatively, 29.5% of Dyadic International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryDyadic International beats Cardio Diagnostics on 7 of the 11 factors compared between the two stocks. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.20M$2.99B$5.47B$9.53BDividend YieldN/A2.43%4.73%4.09%P/E RatioN/A17.7428.8923.83Price / Sales339.03178.71371.4466.13Price / CashN/A41.9535.4557.96Price / Book0.558.508.265.54Net Income-$8.38M-$55.06M$3.25B$259.28M7 Day Performance-13.37%-3.99%-3.73%-4.66%1 Month Performance6.89%9.58%4.28%4.40%1 Year Performance-70.61%6.70%25.85%17.92% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics3.1103 of 5 stars$3.88-6.3%$60.00+1,446.4%-71.8%$7.20M$19.90K0.001Gap DownDYAIDyadic International2.0731 of 5 stars$1.00+2.7%$6.00+500.0%-25.6%$29.30M$3.49M-5.007News CoveragePositive NewsGap UpSCYXSCYNEXIS0.4569 of 5 stars$0.71-1.9%N/A-66.6%$28.29M$3.75M-1.2760Upcoming EarningsENLVEnlivex Therapeutics2.4952 of 5 stars$1.19flat$10.00+740.3%+9.8%$28.15MN/A-1.8070News CoverageAnalyst ForecastShort Interest ↑Gap DownNRSNNeuroSense Therapeutics2.0731 of 5 stars$1.93-5.4%$14.00+625.4%+58.8%$27.88MN/A-3.5710News CoverageGap DownGBIOGeneration Bio3.7025 of 5 stars$0.42+3.6%$8.00+1,800.2%-86.7%$27.24M$19.89M-0.39150Upcoming EarningsGap DownHigh Trading VolumeNNVCNanoViricides0.6559 of 5 stars$1.69+0.6%N/A-24.8%$27.16MN/A-2.3520Gap DownHigh Trading VolumeALXOALX Oncology3.2496 of 5 stars$0.48-5.3%$3.30+587.5%-81.5%$27.05MN/A-0.1940QTTBQ32 Bio1.6367 of 5 stars$2.18-0.5%$12.17+458.1%-94.7%$26.77M$1.16M-0.4439Upcoming EarningsShort Interest ↑FBLGFibroBiologics3.1008 of 5 stars$0.67-0.6%$13.00+1,848.4%-87.1%$26.64MN/A-3.1810News CoverageEarnings ReportUpcoming EarningsAnalyst ForecastRANIRani Therapeutics1.8951 of 5 stars$0.42+1.1%$7.33+1,646.0%-80.6%$26.27M$1.03M-0.42110Negative NewsUpcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies DYAI Competitors SCYX Competitors ENLV Competitors NRSN Competitors GBIO Competitors NNVC Competitors ALXO Competitors QTTB Competitors FBLG Competitors RANI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDIO Stock Alerts